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1. Introduction  
Infection is one of the most frequent and major complications in patients with burn injuries 
and is the main cause for prolonged in-hospital stay and death in cases of wide-spread 
burns despite marked progress in the development of treatments methods for these patients. 
Burn infections get complicated by the development of multi-resistant organisms. The 
colonization and infection of these wounds are a dual clinical problem. On one hand, a 
slowing of the healing process is possible based on a damaged immune system and 
inadequate perfusion to the wound. On the other hand, the infected wound may be a 
potential source of spreading of antibiotic-resistant microorganisms. The infected wound is 
a cause for pain and discomfort for patients, as well as life-threatening septic conditions. 
Thus, the treatment cost and the medical care increase, respectively.  
The topical treatment of the wound is an integral part of the general treatment of the burns. 
The topical treatment agents should posses some important characteristics such as a broad 
spectrum of antibacterial activity, low resistance level, decreased vapour loss, dehydration 
prevention, limited adverse effects, pain control, ease of use and limited toxic risk. Due to 
the wide variety of suitable agents, the choice of the agent depends on the assessment of the 
wound. The most important considerations for the choice of a burn wound dressing are the 
level of its antiseptic effect, the influence of its bioactive abilities on the epithelization and its 
abilities for management of the wound infection. The perfect dressing for children should 
provide optimal protection, reparation and minimization of pain and burn sequelae. Over 
the last 30 years, the knowledge of the mechanism of wound healing has made incredible 
progress as a result of intensive technological and clinical research. The new technologies 
have focused on the development of antiseptic products releasing the antiseptic agent 
slowly and steadily, which allows a lower and more efficient concentration. The wide-
spread antiseptic agents containing silver have a long history of usage and a wide spectrum 
of activity (Klasen, 2000; Landsdown, 2006; Fong & Wood, 2006). Silver dressings are the 
most commonly and frequently used in burn wound treatment.  
The perfect silver dressing should contain such silver concentration which creates a free (or 
limited) side antibacterial effect. The silver nitrate solution is not applied any more due to its 
toxic effect, change of ionic balance and low penetration in depth. The silver sulphadiazine 
SSD (Flammazine, Dermazin, Silvadene, Silverdin®, etc.) is the most frequently used agent 
for topical treatment of children with burns. SSD has a powerful antibacterial effect against a 
broad spectrum of Gram-positive and Gram-negative bacteria, and especially MRSA and 
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Candida spp. The antibacterial effect can be achieved two hours after application and its 
maximum activity lasts approximately six hours. The majority of the comparative clinical 
studies, utilizing biological and non-biological dressings, involves silver sulphadiazine, 
which shows that it is used as a standard agent for treatment in most burn centres (Huang  
et al., 2007; Cuttle et al., 2007).  
Creams and solutions containing silver have been used as main agents in burn wound 
treatment for a long time. Attempts to utilize the excellent antiseptic properties of silver and 
keep the principles of maintaining the moisture environment in the wound on the one hand, 
and avoid the disadvantages of SSD and silver nitrate on the other, have led to the 
development of a new generation of silver dressings. New technologies allowing 
impregnating substances with “antimicrobial” effect in materials or medical equipment 
have been exploited. Silver dressings have preventive and healing effect on the wound 
surface (Burrell, 2003; Orvington, 2001).  
The new silver-impregnated dressings, developed over the last 20 years, have overcome to a 
great extent the disadvantages and limitations of the older silver dressings and especially 
the fast silver inactivation. In these new dressings, when silver is consumed by interaction 
with target cells or inactivated by protein and anion complexes in wound exudate, 
additional silver is released in the wound. Thus, a sustained and steady supply of active 
silver is achieved on the wound surface (Leaper, 2006). The innovation in these dressings is 
not the properties of silver, which are well-known, but the amount of silver incorporated in 
the dressings themselves. Since the properties of silver are beyond doubt, the choice of 
dressing is determined by the characteristics of the silver-carrying material and by the way 
of silver delivery to the wound. The dressing components vary as well including mesh, 
nylon, hydrocolloid or methylcellulose. In order to be biologically active, the structure of 
silver should have dissolution properties, e.g., Ag+ or Ag0. Ag+ is a known ionic form 
present in silver nitrate, silver sulfadiazine and other ionic silver compounds. Ag0 is the 
metallic or uncharged form of silver occurring in crystalline and nanocrystalline silver 
structures (Demling & De Santi, 2001; Orvington, 2001). 
 In the treatment practice, various silver-impregnated dressings are used. Dressings of this 
type differ mostly in their silver “reservoirs”. Some examples are Acticoat (Smith & 
Nephew), Actisorb Silver 220 (Johnson & Johnson), Aquacel – Ag (Convatec), Arglaes 
(Medline, Mundelein), Contreet – H (Coloplast, Marietta), SilvaSorb (Medline) and 
Silverlon® (Argentum LLC). The comparison of the silver dressings is usually based on the 
bacteriology (Cavanagh et al., 2010). Thus, differences are noticed in the field of inhibition, 
with Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration 
(MBC) as a result of the antimicrobial activity of the agent. The results of the in-vitro studies 
of these products with respect to their antimicrobial effect are comparatively identical, and 
most of them demonstrate that Acticoat has a more powerful and broader-spectrum 
antibacterial effect (Yin, 2003; Yin, Langford & Burrell, 1999). For example, MIC is reached in 
concentration of Ag at the range of 5-50 ppm for the most bacteria of clinical interest and 
60.5 ppm for MRSA. Ag concentration for Acticoat is 70 ppm. Acticoat and Aquacel-Ag are 
shown to be most efficient among the silver-impregnated dressings. It has to be pointed out 
that only few prospective clinical studies on the use of these products in patients with burns 
have been published. The nanocrystalline silver dressing was produced using 
nanotechnology and was introduced by R.E. Burrell in 1998 (Wright et al., 1998; Burrell et 
al., 1999). 
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Acticoat has biological, clinical and practical advantages. The biological advantages are: i) 
excellent antimicrobial activity; ii) decrease in the inflammatory reaction of the wound by 
diminishing exudation and control of wound contamination; and iii) creation of optimal 
environment for the healing process of the wound by maintaining moisture, stimulating 
epithelization and controlling wound contamination (Gravante et al., 2009). 
The antimicrobial activity of silver ions has been studied in detail. It has been found that this 
activity is due to: i) interruption of the cell respiratory chain; ii) intervention in the electronic 
and ionic transport of the bacterial cell; iii) attaching to bacterial DNA and influence on cell 
replication; and iv) interaction with the cell membrane and damaging of its structure and 
receptor function.  
The aim of our study was to assess the quality and efficacy of the nanocrystalline silver 
dressing in treatment of burn wounds and to determine the potential advantages over the 
older silver dressings. 
2. Materials and methods 
2.1 Prospective clinical study involving children treated with Acticoat 
A prospective clinical study involving a clinical contingent of 112 children treated with 
Acticoat has been carried out. The protocol was approved by the local ethics committee and 
written informed consent was provided by the children’s parents prior the commencement 
of the study. The approval of reporting the results of the study has been obtained. The 
nanocrystalline silver dressing has been applied on children of both genders, stationary 
treated for a period of one and a half year in 2009 and 2010. ActicoatTM and Acticoat Flex 
with 3- and 7-day-wear time have been used. ActicoatTM consists of three layers – two outer 
and one inner. The inner layer is an absorbent core of rayon and polyester, which controls 
the silver release. The two outer layers are a silver-coated, high-density polyethylene mesh. 
The silver dressing coating has a specific physical structure consisting of silver 
nanocrystalline, organised in a coarse columnar structure. The thickness of the silver layer is 
approximately one micrometer and contains 0.24±0.4 mg silver per mg polyethylene mesh. 
Acticoat-7 dressing consists of three layers of polyethylene mesh coated with 
nanocrystalline silver and two layers of rayon polyester.  
Acticoat Flex is a new, modern formula of the unique silver nanotechnology. Acticoat Flex 
has an open-weave structure. The open weave structure allows good contact with the 
wound and easy exudate migration, thus reducing the risk of maceration and does not 
require constant moistening. The dressing can be perfectly combined with vacuum negative 
pressure therapy in cases of soft tissue defects.  
The monitored children were in the group age of 9 months to 18 years (mean age – 5.26 
years) and had burn area of 0.5% to 95% (mean – 7.89%). The burn wounds had various 
depth and localization. Among them predominated the second-degree superficial burns 
(IIAB. The studied contingent was grouped into five groups: 
- The first and largest group comprised 78 children with second-degree superficial burns 
(IIAB) having mean burn area of 6.82%; 
- The second group involved 19 children with deep burn wounds – mean area of the 
deep burn wounds of 15.76%. 
- The third group comprised 5 children on whom the Acticoat dressing was applied on 
excised wounds with mean area of 6.75%. 
- The fourth group comprised 5 children with application of the dressing on autografts. 
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- The fifth group comprised 5 children with application of the dressing on fresh donor 
sites.  
The assessment methods used included clinical, microbiological, statistical and photo 
documentation.  
2.2 Comparative analysis 
A comparative clinical and cost analysis between Acticoat™ and SSD (Dermazin) has been 
carried out, since the latter agent has proven antiseptic properties and is widely used for the 
treatment of burns in children in comparison with the other epithelotonic and less antiseptic 
agents such as iodic and chlorine-hexidine (Tonkin & Wood, 2005). The clinical contingent 
for this comparative analysis is different from the previous one and involved 111 children. 
The patients were randomized into two groups. The comparative assessment has been 
performed for 68 children with Acticoat™ and 43 children with Dermazin and the 
following parameters have been monitored: 
- Clinical – wound type (initial and post dressing change), wound clearing time, 
epithelization time and hospital stay; 
- Microbiological – dynamically monitoring the microbial flora, prior and post each 
dressing change; 
- Pharmacological and cost parameters. 
2.3 Method of use 
The way of application depends on the type of Аcticoat. The application is easy and 
identical regardless of the age, area, localization and the depth of the burn, excised area, 
area covered with autograft or donor site. The wound areas are mechanically cleaned by 
hydro-procedure using Hibiscrub. Prior to use, ActicoatTM is moistened with sterile water 
and applied on the burn wound, excised area, autograft or donor site. The dressing is 
trimmed according to the shape of the treated area. ActicoatTM is covered with a four-layer 
moistened gauze followed by four layers of dry gauze whose purpose is to drain the surplus 
amount of fluid. The dressing is held in place with a bandage or mesh. The moisture 
maintenance is an important condition for the dressing efficacy and can be done by means 
of the following two ways: 
- Moistening the dressing by irrigation or watering once or twice daily. The outer gauze 
layer is changed.  
- Covering the dressing with polyethylene foil which helps maintain moisture.  
An alternative but a more expensive way to maintain the moisture is to use Intrasite gel or 
Allevyn foam. 
In case of heavy exudate wounds, additional moistening of the wounds is not necessary. The 
dressing is changed 3 or 7 days after application, but this period may differ depending on 
the estimation. Acticoat Flex is used after an identical preparatory wound treatment and is 
moistened with sterile water prior to application. It is cut to the desired shape and size, and 
exploiting its elasticity applied to the wound area. The dressing is covered with a four-layer 
moistened gauze followed by four layers of dry gauze. It is not additionally moistened until 
the next dressing. In wide spread burns, the dressing change is performed by using a 
general anaesthesia (Tancheva, 2008). In cases of limited and small burn areas, a general 
anaesthesia is not necessary due to the painless dressing change.  
Microbiological quantitative (tissue biopsy samples) and qualitative (wound surface swab) 
analysis of the flora in the treated areas were carried out before initial application and at 
www.intechopen.com
 Application of the Nanocrystalline Silver in Treatment of Burn Wounds in Children 
 
241 
every dressing change. The studied contingent was monitored for presence of pain or 
discomfort after the dressing as well as for side effects – general and local.  
The treatment of 62 children from the first group started within 24 hours after the burn and 
for the remaining 16 children –24 hours after the burn. The treatment of 7 children from the 
second group began within 24 hours after the burn and for the remaining 12 children - 
within 42 hours.  
In all burn centres SSD is changed every 12 hours. In this study the Dermazin dressings 
were changed every 24 hours. The microbiological analysis was performed at the beginning 
of the treatment and at every dressing change. The closed method of application was used. 
After a hydro-procedure with Hibiscrub and cleansing using disinfection solution, the agent 
of 2-3 mm layer was applied directly on the wound and covered with dry, sterile and dense 
bandage-gauze dressing (Atiyeh, 2009). 
3. Clinical observations 
3.1 Clinical observation of the wounds treated with Acticoat 
The treatment with Acticoat of the first group of children (78) with superficial burns was 
conducted according to the described method. Decreasing of the exudation and demarcation 
of devitalized tissue was observed as early as in the first dressing. In wounds and areas of 
second degree (IIA), the dermis was deeply red with beginning epithelization. In cases of 
abundant exudation and of deep dermal burns, a bright and jelly-like coating was observed 
on the wound surface and the Acticoat bed, which was caused by protein coagulation. 
Attempting to remove this coating led to heavy wound bleeding. The wound resembled the 
“infected” one, but bacterial growth was absent. There was no inflammation area around 
the wound. A dark brown or grey pigmentation of the wound and intact skin was observed, 
which was transient and disappeared within 2 to 14 days. The intact skin was changed by 
the hydration but not macerated. The hydrated skin appeared white or lighter than the 
surrounding skin with a wrinkled or prune-like look, while the macerated skin was soft and 
tissue became bright red, progressing to blistering and breakdown. When Аcticoat Flex was 
applied on this type of burns, a good fixation of the agent on the wound and hardly any 
exudation was observed. In most cases, the dressing could be removed only after a 
prolonged moistening. The dressing structure allows good control of the wound and a new 
dressing was not applied, regardless of the Аcticoat Flex wear time (3 or 7 days), providing 
the dressing was properly fixed. When the dressing was applied on a heavily exudating 
wound, the exudation decreased after one or two dressings (6 children). The exudation level 
was subjectively assessed by the type and size of the coating on the wound surface and on 
the dressing. In burns above 10%, where wound infection was not present, smell appeared 
after the removal of the dressing. The patients did not feel pain immediately after the 
dressing application and between the dressing changes.  
A discomfort after the dressing application was observed in 8 children, which disappeared 
within 3-4 hours. In the deep dermal burn wounds, a very rapid demarcation and removal 
of the necrotic tissue was observed (in the 2nd or 3rd dressing). The mean wound clearing 
time is 8.92 days and the mean epithelization time is 12.98 days, shorter in comparison with 
the agents used thus far. The second (IIA) degree burn wounds epithelialized within 5-6 
days. In the case of cleared wound and beginning epithelization, the dressing could be 
replaced by another type of epithelotonic dressing such as Bactigras. (Bactigras is a sterile 
gauze dressing made of cotton impregnated with soft paraffin containing 0.5% 
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chlorhexidine acetate). When the Аcticoat dressing was applied on infected wounds, the 
clinical type of the wound remained the same, but the coating on the dressing bottom was 
more mucous and thick, and a 4-5-day delay in the wound clearing was observed. Wound 
sites in which a pathogenic flora was isolated during the treatment did not clinically change 
the wound type. In these rare cases the only clinical sign was the delay of the wound 
clearing and epithelization, respectively. 
The application of Acticoat™ and Аcticoat Flex for treatment of superficial burns is 
demonstrated (Figures 1-15). 
 
  
Fig. 1. The beginning of treatment Fig. 2. Result after the 1st dressing 
 
  
Fig. 3. Result after the 2st dressing – complete epithelization 
 
 
 
 
Fig. 4. Final result – 30th day after the burn 
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Fig. 5. The beginning of the treatment with Acticoat™ of a left arm with deep dermal flame 
burn – 
 
 
  
Fig. 6. Wound condition after the 1st 
dressing 
Fig. 7. Wound condition after the 2nd dressing 
 
 
 
 
 
 
Fig. 8. Wound condition after the 3rd dressing – 
epithelialized surface with scattered small wounds and 
distinguished hyperpigmentation resulted from the 
application of the silver dressing 
 
Fig. 9. The 16th day after burn. 
Full epithelization with 
disappearing 
hyperpigmentation 
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Fig. 10. Final outcome 
 
  
Fig. 11. Scalding of the right leg Fig. 12. Covering the wound with Acticoat 
Flex 7 
 
 
 
 
Fig. 13. The result after the 1st dressing on the 
7th day of the treatment 
Fig. 14. Epithelializing wound covered 
with Acticoat Flex 
 
  
Fig. 15. The 12th day of the treatment – fully 
epithelialized wound of the thigh and 
progressing wound epithelization of the 
lower leg 
Fig. 16. Early result (15th day) – removing 
of the dressing after moistening. The 
wound is almost fully epithelialized 
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The dressing was applied on 19 children from the second group with deep burns with 
various area (from 0.5% to 95%, mean – 15.76%) and various localization. All children 
underwent operation. An early surgical excision at one, two or three stages was performed 
on 16 children between the 2nd and the 6th day after the burn. Three children were operated 
on after the 10th day of the burn. The dressing changes for this group conformed to the times 
of surgical treatment. On those patients operated on after the 10th day, the dressing was 
applied according to the described standard method. The demarcation and separation of the 
devitalized tissue in these patients occurred after the second or third dressing. The burns 
were clear and without exudation. The formed necroses were greenish and not dry for 
Acticoat™, while those for Acticoat Flex were greenish-brown and drier. Dressing removal 
was easy and without bleeding, and a clear wound with a short and fresh granulation was 
formed, ready for autografting.   
In 5 children from the third group, Acticoat was applied on fresh excised sites of burn 
wounds (mean area of 6.75%), where multistage excision was carried out. After the dressing 
removal, the excised site was covered with bright yellow coating without smell and 
exudation. This coating could be easily removed and the wound area was fresh and ready 
for autografting without any additional surgical treatment. Hyperpigmentation of the 
wound was not observed.  
The dressing was applied on autografts in 5 of the clinically monitored children, who had 
above 15% burn and deep burn area ranging from 6% to 72%. Using the standard method, 
Acticoat was applied directly on the autografts, which had various areas (300 cm2 to 800 
cm2) and was meshed at 1:2 ratio using mesh-graft dermatome (1:4 ratio for one patient 
only). The dressing was removed on the 4th day after the operation (in two children on the 
5th day) and well-healed autografts with hyperpigmentation, scant smell and without 
exudation was observed. The epithelization of the mesh splits was 95%.  
In 5 children, the dressing was applied on fresh donor sites situated on the thighs. The 
autografts with thickness of 0.2 – 0.5 mm were harvested from these areas with electric 
dermatome. The standard way of dressing application was used. After the removal of the 
dressing on the 4th day, the donor site had pink colour and was covered with silver scattered 
particles. This site did not have any smell, exudate or coating. Epithelization of 95% occurred in 
one child on the 4th day. The complete epithelization occurred in the remaining patients within 
8 days after the dressing application. Hyperpigmintation of the intact skin was observed in all 
patients. The donor sites were monitored up to six months after the epithelization and there 
were no signs of hypertrophic scarring according to the Vancouver Scar Scale (VSS). 
The following figures demonstrate a clinical case with ActicoatTM application (Figures 17-
28): i) treatment of deep burns localized on the legs; ii) application on excised area; iii) 
application on auto- and allograft; iv) application on donor sites. 
 
  
Fig. 17. Deep burn Fig. 18. Application of ActicoatTM as a pre-
operative preparation 
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Fig. 19. Total surgical excision 
 
  
Fig. 20. Application of ActicoatTM on fresh autograft  
 
 
 
 
Fig. 21. A stable whole autograft on knee and condition of the excised site on the lower leg 
after ActicoatTM removal 
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Fig. 22. A stage of the treatment – healed autografts in the knee area, healed autografts in the 
right lower leg; and clinical condition of the excised site on the left lower leg after ActicoatTM 
application 
 
  
Fig. 23. Autografts covered with Acticoat and donor sites on both legs 
 
  
Fig. 24. Donor sites after the 1st ActicoatTM 
dressing 
Fig. 25. Epithelialized donor site at the 2nd 
dressing and neighbouring donor site after 
the 1st dressing  
www.intechopen.com
 Skin Grafts – Indications, Applications and Current Research 
 
248 
 
  
Fig. 26. Wounds covered with stable autografts and fully epithelialized donor sites. 
Persistent hyperpigmentation on operated and donor sites due the ActicoatTM use 
 
 
 
 
Fig. 27. Outcome at the end of the treatment and beginning of the prophylaxis of the scars 
with silicone sheets   
 
 
  
Fig. 28. The patients after the end of the treatment 
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3.2 Clinical observation of the wounds treated with Dermazin 
The application time of the agent was registered until the beginning of stable epithelization 
of the wound in the patients with superficial burns. In the deep burns, this period included 
the time until the wound clears or the surgical treatment begins. The local treatment 
continued further with other agents for both groups of patients, depending on the wound 
type. In 32 patients with superficial burns, on which Dermazin was applied, the wounds 
were covered with “an abundant amount of fester-like exudate”, which created an 
impression of worsened local status (Figure 29). The bacteriological analysis showed that in 
most of the cases this exudate was sterile and was caused by the mixing of the wound 
exudate and the agent. Forming of “pseudonecrosis”, which was difficult and painful to 
remove, was observed (Figure 30). For this reason, the dressing change required general 
anaesthesia even in burns with small area. Moist and soft necroses with grey metallic colour, 
which were irremovable, were observed in deep-dermal and deep burn wounds (Tonkin & 
Wood, 2005). In patients who did not undergo operations, these necroses were slowly and 
tangentially detached in due course. In case of local infection, the dressings were wet at the 
time of dressing change due to the abundant amount of exudates, while swelling, 
reddening, firm wound edges and smell were observed. 
 
  
Fig. 29. Clinical state of a wound treated with 
Dermazin 
Fig. 30. Formed “pseudonecrosis“ after the 
treatment with Dermazin 
3.3 Bacteriological analysis  
Acticoat is a dressing with a silver coating and unique physical structure of silver 
nanocrystalline, which in a moist environment provides a long-lasting and steady release of 
free silver ions and radicals on the surface of a burn wound. Although Acticoat releases 30 
times less silver than 0.5 per cent solution of silver nitrate (AgNO3) and SSD, it has a much 
quicker and more powerful antibacterial effect. It is an effective agent against Gram-positive 
and Gram-negative microorganisms, including aerobic and facultative anaerobic organisms 
and fungi. It is effective against all pathogenic microorganisms isolated from burn wounds, 
especially Pseudomonas aeroginosa, Staphylococcus aureus – MRSA and VRE (Tredget et 
al., 1998). Its antiseptic effect is revealed within 30 minutes of the application and lasts up to 
3 days (Wright et al., 1999). The Minimum Inhibitory Concentration (MIC) and the 
Minimum Bactericidal Concentration (MBC) of the three silver dressings (Acticoat, AgNO3 
and SSD) have been spectrophotometrically studied, determined and compared using five 
bacterial strains, which are  of clinical interest (Demling & DeSanti, 2002). Acticoat has the 
lowest MIC and MBC in comparison with the other two silver dressings. Due to these 
laboratory proven results, a preliminary in vitro analysis has not been carried out. The 
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investigation of the results from the bacteriological analysis after the Acticoat application 
indicates that (Figures 31-35):  
- The wounds of 96 children (86%) were without bacterial growth at the beginning of the 
treatment with Acticoat and remained unchanged in 95 children until the end of the 
treatment. 
- A Gram-positive and Gram-negative flora was isolated in 16 children at the beginning 
of the treatment (5 with Staph.aureus-MRSA, 2 with Str.ß haemoliticus and 6 with 
Staph.epidermidis).  
- In one child with uncontaminated wound at the beginning of the treatment, the wound 
became colonized by Ps. aeroginosa (microbial number was below the critical value of 
103, 102) during the treatment course. 
- Bacterial growth was not observed in 109 children (97%) at the end of the treatment. 
Contaminated wounds of two children at the beginning of the treatment remained 
unchanged even after the third dressing, but the microbial number was below the 
critical values (1 child with Ps. aeroginosa 103 and 1 child with Staph.aureus-MRSA 
102). 
 
 
Fig. 31. Bacterial growth distribution during the treatment with Acticoat 
 
 
Fig. 32. Distribution of the bacteria and bacterial growth at the beginning of the treatment 
with Acticoat 
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Fig. 33. Distribution of the bacteria and bacterial growth at the end of the treatment with 
Acticoat 
 
 
Fig. 34. Distribution of the bacteria at the beginning of the treatment with Acticoat 
 
Fig. 35. Distribution of the bacteria at the end of the treatment with Acticoat  
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4. Comparative analysis between Acticoat™ and SSD (Dermazin) 
4.1 Comparative bacteriological analysis between Acticoat™ and SSD (Dermazin) 
A comparative bacteriological analysis between Acticoat™ and SSD (Dermazin) has been 
carried out. The following parameters have been monitored: 
- The type of the bacterial flora (wound surface swab) before the Acticoat™ application; 
- The type of the bacterial flora (wound surface swab) after each removal of the dressing. 
The dressings were changed every 3 days according to the already described way; 
- The quantity of the bacterial flora (tissue biopsy samples) in gram wound tissue 
(microbial number), before and after the application of the agent. The critical value for 
development of a local and general infection of the wound is 105 bacteria per gram 
tissue (b/gr). 
The performed prospective clinical study comprised 111 patients – 68 (61.26%) of them were 
treated with Acticoat™ and 43 (38.74%) with Dermazin. The gender distribution is: 67 males 
(60.36%) and 44 females (39.64%). The average age of these children was 4.78±4.38 years in 
the age range of 9 months – 18 years. The total number of the burns was 265: 151 (56.98%) of 
which were treated with Acticoat™ and 114 (43.02%) with Dermazin. 
4.1.1 Results 
It could be seen from Tables 1 and 2 that the patients included in the sample do not 
statistically differ with respect to age, burn area and burn depth. The further analysis shows 
that there is no significant difference of gender distribution. The initial similarity of the main 
confounding factors gives a good basis for the comparison of the outcome obtained from the 
treatments with the two agents.  
 
Parameter 
Treated with Acticoat™ Treated with Dermazin 
p 
N X  SD N X  SD 
Age 66 4.65 4.11 43 4.97 4.80 n.s. 
Burn area 68 7.65 5.95 43 9.95 7.84 n.s. 
Table 1. Comparative analysis of the age and burn area of the patients treated with the 
studied agents ( X - mean value, SD- standard deviation, N- number, n.s. – not significant) 
4.1.2 Initial status of the patients treated with the two agents with respect to bacterial 
flora 
It is clear from Table 3 that bacterial flora is registered in 17.65% of the patients treated with 
Acticoat™ and in 13.95% of those treated with Dermazin. The Fisher’s exact test classifies the 
difference with respect to this parameter as non-significant. The ratio of the bacterial findings 
deep in the wound was identical to those on the surface at the beginning of the treatment.  
4.1.3 The status of the bacterial flora on 4th day after the first dressing 
The technology of treatment with the two agents allows comparison of impact only on the 
4th day after the first dressing. The bacterial flora decreased from 17.65% at the beginning of 
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Degree Statistics 
Agent 
Total 
Acticoat™ Dermazin 
ІІ A 
Number 54 38 92 
% w.r. degree 58.70 41.30 100.00 
% w.r. agent 40.91 43.18 41.82 
ІІ B 
Number 62 40 102 
% w.r. degree 60.78 39.22 100.00 
% w.r. agent 46.97 45.45 46.36 
ІІІ 
Number 16 10 26 
% w.r. degree 61.54 38.46 100.00 
% w.r. agent 12.12 11.36 11.82 
Total 
Number 132 88 220 
% w.r. degree 60.00 40.00 100.00 
% w.r. agent 100.00 100.00 100.00 
Table 2. The sample participants distribution with respect to the burn degree and agent  
(w.r. - with respect to) 
 
Bacterial flora 
on the surface 
Statistics 
Agent 
Total 
Acticoat™ Dermazin 
Absence 
Number 56 37 93 
% w.r. flora 60.22 39.78 100.00 
% w.r. agent 82.35 86.05 83.78 
Presence 
Number 12 6 18 
% w.r. flora 66.67 33.33 100.00 
% w.r. agent 17.65 13.95 16.22 
Total 
Number 68 43 111 
% w.r. flora 61.26 38.74 100.00 
% w.r. agent 100.00 100.00 100.00 
Table 3. The sample participants distribution with respect to the agent and existence of 
bacterial flora (w.r. - with respect to) 
the treatment up to 16.18% on the 4th day for Acticoat™, while an increase from 13.95 up 
to 25.58% was observed in the patients treated with Dermazin. The change is significant, 
but it is in favour of the treatment with Acticoat™. On the 4th day of the treatment the 
ratio of the bacterial findings deep in the wound was completely identical to that on the 
surface. The dynamics of the change of the bacterial findings for the two agents on the 1st 
and 4th (Figure 36).  
The dynamics of the change of the bacterial flora on the surface, treated with the two agents, 
showed that from 4 bacterial findings of Staph.aureus - MRSA at the beginning of the 
treatment with Acticoat™ only one was isolated on the 12th day, whereas from 3 bacterial 
findings of Pseudomonas aeroginosa two were present, while the other initial bacterial 
findings were killed. 
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Fig. 36. The dynamics of the bacteria change for the two agents on the 1st and 4th day 
In the treatment with Dermazin, an increase in the present bacterial findings or appearance 
of new ones in the course of treatment up to the 4th day were observed. This is most  
pronounced for Acinetobacter and Pseudomonas aeroginosa with respect to quantity. There 
was a decrease in Staph.aureus - MRSA from 5 to 3 findings and complete clearing of 
Str.beta haemoliticus (from 1 to 0), but the sterility as a whole aggravated for this agent on 
the 4th day (Figures 37-39). 
The results of the deep analysis of the bacterial flora also showed the advantages of the 
treatment with Acticoat™ (Figures 40-42). The patients treated with Acticoat™ have worse 
bacteriological status in the beginning and significantly better dynamics on the 4th day of the 
treatment, while a worsening of the sterility in the deepness is observed for the patients 
treated with Dermazin. In one patient treated with Acticoat™, bacterial flora was observed 
only on the surface, but not in the deepness on the 8th and 12th day. 
 
 
Fig. 37. Bacterial growth distribution during the treatment with Dermazin 
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Fig. 38. Distribution of the bacteria at the beginning of the treatment with Dermazin 
 
 
Fig. 39. Distribution of the bacteria at the end of the treatment with Dermazin 
 
 
Fig. 40. Bacterial growth distribution during the treatment with Acticoat 
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Fig. 41. Distribution of the bacteria at the beginning of the treatment with Acticoat 
 
 
Fig. 42. Distribution of the bacteria at the end of the treatment with Acticoat 
4.2 Comparative analysis of the patients treated with the two agents with respect to 
clearing time, epithelization and hospital stay 
The results unambiguously illustrated that Acticoat™ possesses significantly better 
therapeutic effect in comparison with Dermazin (Figures 43-56; Table 4). It was clear that the 
burns treated with Acticoat™ had significantly shorter clearing/ epithelization time and 
hospital stay (Table 4).  
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Fig. 43. Distribution of the wound clearing time 
 
 
Fig. 44. Distribution of the wound epithelization time 
 
 
Fig. 45. Distribution of the hospital stay 
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Fig. 46. Mean wound clearing time, mean  epithelization time  and mean hospital stay 
 
Parameter 
Treated with Acticoat™ Treated with Dermazin р 
N X  SD N X  SD 
Clearing day 66 8.92 3.16 43 14.93 2.20 <0.001 
Epithelization 
time (days) 
60 12.98 4.02 39 19.79 3.02 <0.001 
Hospital stay 
(days) 
66 16.95 6.19 42 26.90 6.91 <0.001 
Table 4. Comparative analysis of the patients treated with the studied agents with respect to 
clearing time, epithelization time and hospital stay 
The performed comparative statistical analysis (t-test) reveals that the differences of 
application of Acticoat™ and Dermazin were statistically significant. The obtained p-value 
for the three tests (comparison of the clearing time, epithelization time and hospital stay for 
the two agents) was p<0.01. The Mann-Whitney test was applied for the statistical analysis 
of the bacterial growth (microbial number) and the obtained value (p=<0.01) implied that 
the difference of application of Acticoat™ and Dermazin for the treatment of the monitored 
patients was statistically significant. This analysis showed statistically significant differences 
between the application of Acticoat™ and Dermazin with respect to the clearing time, 
epithelization time, hospital stay and microbial growth. 
The comparative clinical and microbiological analysis between the two silver agents revealed 
that treatment with Acticoat™ achieves better efficacy in killing superficial and deep bacterial 
flora and yielded faster wound clearing, epithelization and shorter hospital stay. 
4.3 Side effects 
Three children of the observed contingent treated with Acticoat™ developed rash, which 
was transient and faded quickly. The most probable reason for the rash was due to the 
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occlusive effect of the dressing caused by the polyurethane foil. Toxic effects were not 
observed. The hyperpigmentation of the intact skin was transient and disappeared within 14 
days after the end of the treatment or dressing change. In the children of the control group 
with Dermazin no toxic and allergic reactions were observed. Cases of argyria were not 
observed.  
4.4 Comparative cost analysis between Acticoat™ and SSD (Dermazin) 
The comparative cost analysis was based on the treatment of a burn wound of second 
degree (IIAB) with 2000 cm2 area. One surgeon, one anaesthesiologist, one surgical nurse, 
one anaesthetic nurse and one hospital attendant were involved for application of both 
agents. Table 5 shows the cost comparison of both agents.  
 
 Acticoat™ Dermazin 
Labour cost per dressing ( L)  € 13.36 € 13.36 
Materials per dressing  (M) € 311.65 € 93.60 
Total Cost per dressing (L+M) € 325.01 € 106.96 
Dressing numbers (n) 4 20 
Total (Euros) - (L+M)*n € 1300.04 € 2139.20 
Table 5. Comparative cost (in Euros) analysis of the treatment of a burn (2000 sm2) of second 
(IIAB) degree for both agents 
The cost comparative analysis demonstrated that the treatment of a second degree (IIAB) 
burn wound (2000 cm2 area) with Dermazin was more expensive by approximately € 839 
(65% more expensive) than the treatment with Acticoat. 
5. Discussion  
General concepts and techniques for treatment of all wounds are applied regardless of the 
mechanism causing the wound. The key to high quality and proper local treatment is the 
correct and complete assessment of the burn wound. This includes etiology, localization, 
area (cm2), depth, exudation (quantity, type, colour), smell, appearance of the wound 
surface, appearance of the intact skin, presence of pain, and prior treatment method. The 
treatment goals are determined on the basis of proper assessment preceding the treatment. 
The burn wound changes dynamically depending on inner (release inflammatory 
mediators, bacterial proliferation) and outer (dehydration, hypotension and cooling) factors. 
Thus, the applied local agent is subjected to permanent control (both objective and 
subjective). The perfect dressing for children should provide optimal protection, reparation 
and minimization of the pain (Khundkar et al. 2010). 
Silver-impregnated Acticoat™ dressing has been used in the Clinic of Burns at the 
“Pirogov” Emergency Hospital since 2004 and has gradually prevailed as the standard 
dressing in the treatment of burn wounds and post-traumatic defects. The clinical studies, 
conducted in the Clinic of Burns in Children in the second half of 2009 and 2010, 
demonstrate the advantages of topical treatment with nanocrystalline silver and was 
concluded that the agent was efficient in all cases and was easily tolerated. The less frequent 
and atraumatic dressing changes make this agent a preferable one for children. The clinical 
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observations of the use of Acticoat ™ and the comparative analysis with Dermazin show 
that the time of dressing changes is reduced by 50%, since the dressing change is every 3rd 
day, in contrast to the Dermazin dressing, which has to be changed every 12 hours. This 
yields a reduced use of sedative and narcotic agents applied in dressings as well as less 
stress in dressing change, respectively (Probert & Burston, 2005). 
Prior to the development of this type of dressing, it was considered that moist environment 
contributes to increased risk of infection. The clinical observations of many authors (Ang et 
al., 2003; Fong & Wood, 2006; Wright, et al. 2002) as well as our own studies reject such 
concern. Dermazin and other types of SSD extract water from the wound surface as a result 
of the cream hyperosmolarity, which requires frequent change. All the advantages, which 
the moist environment has for the healing process, pose the question of maintaining the 
moisture (Fong, 2005). The moistening of Acticoat has double effect – to maintain the moist 
environment in the wound and to release the antimicrobial power of nanocrystalline silver. 
The results (clinical and bacteriological) of polyethylene foil application, as an instrument 
for moisture maintaining, are very good. Everyday moistening by irrigation or change of the 
upper gauze layers is unpractical and more difficult to control. Use of Intrasite gel and 
Allevyn is expensive and economically disadvantageous, therefore, semi-occlusive dressings 
are utilized. Each modern dressing should possess the property of moisture transmission 
and control. The complete occlusion may create an environment for the development of 
facultative pathogenic microorganisms, causing infection. For this reason, the Moisture 
Vapour Transmission Rate (MVTR) is an important parameter for each modern dressing. A 
value of MVTR = 600-3000 for the polyethylene foil is determined, and a complete occlusion 
occurs at value <500. Excellent moisture maintaining until the next dressing change was 
observed in the monitored clinical contingent and maceration was not observed. The typical 
imbibition was temporal and disappeared immediately after the change of the dressing type 
or after the treatment was discontinued. In cases of infected wounds with abundant 
exudation, an additional moistening is not necessary because the dressing has absorption 
property when it comes in contact with the wound exudates.  
The clinical observations on the contingent studied confirm these properties of Acticoat. The 
comparative study carried out in the clinic shows that the mean time for the wound clearing 
is 8.92 days for Acticoat, whereas for Dermazin it is longer – 14.93 days. Correspondingly, 
the epithelization time is shorter for Acticoat (mean =12.98 days), while for Dermazin the 
mean epithelization time is 19.79 days. This parameter is particularly essential in the 
treatment of second-degree (IIA and IIB) burns, which epidemically have the highest 
incidence rate, and in the treatment of the so-called “mixed burns”, in which the epidermis 
is completely damaged while the dermis is damaged at various levels of thickness. Contrary 
to deep burns, mixed burns have the capacity of spontaneous healing in case of proper 
treatment. The incidence rate of these burns (having in mind a total damaged body area) is 
high, although it has not specially been reported in the literature. While the treatment 
method for the first- and third-degree burns is clearly determined, the algorithm for this 
type of superficial burns is a dilemma (Storm-Versloot et al., 2010). In this case, the active 
surgical behaviour has some disadvantages, since there are not exact demarcations of the 
areas, which will epithelize in time and those which will not close non-operatively. Good 
and fast epithelization of these border burns is very important in widespread burns with 
vast areas of deep burn, where the shortened epithelization time contributes to the quicker 
decrease in the total burn area and to the increase in the area of possible donor sites (Wright 
et al., 2002). The shortened wound epithelization time diminishes the risk of development of 
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bacteraemia and septic condition, which are a major cause of death in burns. Thus, the 
necessity of antibiotic therapy is reduced (Tonkin & Wood, 2005). Earlier wound clearing 
and closing diminishes the risk of development of hypertrophic scars and joint contractures 
on the one hand, and contributes to the child’s faster recovery, on the other. An optimum 
microenvironment and absence of cytotoxic factors are essential for the phase of 
epithelization of the wound healing process. In-vitro studies show that Acticoat is toxic to 
both keratinocytes and fibroblasts, suppressing proliferation at the same time (Andrew et 
al., 2005; Burd et al., 2007; Paddle-Ledinek et al., 2006). The monitored patients’ clinical 
results do not demonstrate such an in-vitro effect. This is confirmed by other in vivo studies.  
Apart from burn wounds, the anti-inflammatory, antibacterial and epithelotonic effect of the 
dressing is utilized in wounds covered with fresh autografts and donor sites (Demling & 
DeSanti, 2002; Olson et al., 2000; Silver, 2007). A faster stabilization and re- epithelization in 
comparison with other types of antiseptic and epithelotonic dressings was observed. Well-
healed autografts and epithelization of the mesh splits (95%), in case of Acticoat application on 
5 children with fresh autografts, was observed after the removing of the first dressing. In 
application on donor sites (5 children) almost full epithelization (96%) was detected in one 
child, and in the remaining 4 children full epithelization was observed on the 8th day. The 
donor sites were monitored up to six months and no signs of hypertrophic scarring appeared.  
The bacteriological observations demonstrate the powerful antibacterial effect of Acticoat. 
The rate and degree of killing of microbes is higher than those of the other silver agents used 
so far, which is due to the specific physical-chemical structure (Dunn & Edwards-Jones, 
2004). After 30 minutes, nanocrystalline silver reduces the number of viable bacteria to very 
low levels, while the other dressings achieve this effect after 2 hours (Wright et al., 1999; Yin, 
2003; Burrell, 2003; Heggers et al., 2005; Lansdown, 2006). Pure silver ions and radicals have 
been shown to provide protection against a broad spectrum of bacteria (more than 150 
types), viruses and fungi and especially antibiotic-resistant bacteria. This effect is prolonged 
and lasts up to 3 days after the dressing application. Acticoat has preventive antibacterial 
function, too. Applied on wounds, which have no bacterial growth, it prevents 
contamination. The dressing reduces the risk of wound contamination, being a highly 
efficient agent for the prevention of general bacterial infection, especially in widespread 
burns (Singh et al., 2007; Nadworny et al, 2010). This is confirmed by the microbiological 
studies carried out (Hadjiiski & Argirova, 2008). Wounds without bacterial growth at the 
beginning of the treatment remained uncontaminated until the end of the treatment, and 
only in one child local infection (below the critical values) was observed during the 
treatment course. From the initially contaminated wounds (in 16 children), bacterial flora 
with non-significant quantitative values was isolated only in 3 children at the end of the 
treatment. Wherever a local infection was isolated, regardless of its type, the microbial 
numbers remained below the critical values and signs of general infection were not 
observed (Figures 31-35). The antimicrobial preventive activity described is essential for the 
successful surgical treatment of widespread and deep burns. The bacterial monitoring of the 
children to whom Acticoat was applied on excised sites, autografts and donor sites (total – 
15) showed a negative bacterial growth. The results of the microbiological analysis are 
assessed as very good in 97%, good in 2% and unsatisfactory in 1% of the cases. The use of 
Acticoat does not lead to the development of resistant bacterial strains. The distinct agent 
action -superficial and in depth - against Ps.aeroginosa and St.aureus MRSA, which is 
demonstrated by the obtained results, make the dressing preferable for burn wounds (Chae 
et al., 2010). Thus, the need of antibiotic therapy is reduced, leading to a decreased risk of 
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the development of multi-resistant strains. A fungal infection was not isolated in the studied 
children. The Acticoat™ low adherent property allows a less painful dressing change, which 
makes it a preferable dressing for children (Tancheva, 2008). The long-lasting activity of the 
dressing reduces the total number of dressing changes. This yields better comfort, mobility 
and ability of the patients to participate in rehabilitation programmes. In the analysis of 
silver serum concentrations, haematological and biochemical parameters of the patients of 
the studied clinical contingent, treated with nanocrystalline silver, no indication for toxicity 
was observed (Moiemen et al., 2011; White, 2010). Due to lack of toxic effect, it is suitable for 
application even on very young children, unlike Dermazin (Rustogi et al., 2005). Side effects 
were not observed in the youngest patient, who was 9 months old. Silver is deposited 
mostly in the skin, oral mucosa, gums, kidneys, liver and cornea. Excretion is done mostly 
by biliary way. Monitoring of the plasma levels is recommended in burns over 10% and 
burns of second (IIB) and third (III) degree, and especially in patients with abnormal liver 
and kidney function (Landsdown, 2006).  
6. Conclusion  
The obtained clinical results, microbiologically and statistically verified, as well as the 
conducted comparative study between Acticoat and Dermazin, provide reasons to consider 
the Acticoat silver dressing as highly efficient for application in superficial burns of second 
(IIA and IIB) degree, pre-surgical treatment of patients, prophylaxis and treatment of 
infection in burns, treatment of donor sites, excised sites and autografts. 
The presented properties of Acticoat allow us to define it as one of the leading agents for 
local treatment of burns. During the short time of its use in our clinic, it has been recognized 
as a preferable agent for wound treatment. The ease of use, powerful antibacterial effect, 
lower frequency of dressing change, variety of sizes, good moulding, shortened time of 
wound clearing and epithelization, and painless dressing change are the advantages of 
Acticoat™ over the other silver agents used so far. Acticoat™ is significantly more cost 
effective than the other frequently used agent Dermazin. 
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